Scholars Central

Conference abstractPublished 2012

Preclinical testing of experimental therapeutics for treating brain tumors: Raising the bar for clinical trial evaluation

Authors: David James

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This lecture will address a variety of topics related to the use of rodent models for pre-clinical evaluation of candidate therapeutics for treating brain tumors, and will include discussion of: maintenance options for tumor cell sources; the importance of appropriate anatomic modeling; brain tumor imaging approaches for orthotopic rodent models (bioluminescence and magnetic resonance); factors affecting experimental outcomes; use of therapeutic nanoparticles and associated administration options; acquired resistance to therapy; and novel combination therapies. In addition to these subjects, attendees of this lecture will be familiarized with the need for rigorous and stringent testing of candidate therapeutics, so that only the most promising therapies are advanced to clinical trial evaluation of efficacy when treating brain tumor patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology & Neurophysiology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “David James”